NCT00872235View on ClinicalTrials.gov

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

July 31, 2005

Study Completion Date

November 30, 2005

Conditions

Healthy

Interventions

DRUG

fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets

Trial Locations (1)

110 062

Ranbaxy CPU, New Delhi

All Listed Sponsors

lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00872235 - Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter